Search

everythinglearnresearchcommunity

for

Search:↓

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Autophagy, a cell recycling process, is crucial for prolonged hair growth and could be a potential target for treating hair growth disorders.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

Some skin medication can rarely cause or worsen mental health issues; knowing this is important because mental health problems are increasing worldwide.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Targeting endolysosomes may help treat COVID-19.

Langsat fruit has health benefits like fighting malaria, bacteria, and aging, but its peel is toxic.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

The diphosphonate was the most effective at preventing calcification in rats.

Hydroxychloroquine may help some hair disorders, but results vary.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Hydroxychloroquine can help treat certain types of hair loss.

Hydroxychloroquine may help treat alopecia areata in children.

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Diphencyprone therapy can effectively treat severe hair loss in motivated patients.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.